| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Diana Di Gioia | |
| Loredana Baffoni | |||
| Francesca Gaggìa | |||
| Nicole Bozzi Cionci | |||
| P2860 | cites work | The gut flora as a forgotten organ | Q24550824 |
| Microbial ureases: significance, regulation, and molecular characterization | Q24594053 | ||
| Synergistes group organisms of human origin | Q24669880 | ||
| The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials | Q27001546 | ||
| The gut microbiota as an environmental factor that regulates fat storage | Q28131676 | ||
| Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases | Q28131810 | ||
| Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic | Q28241661 | ||
| Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children | Q28247362 | ||
| The human gut microbiota and virome: Potential therapeutic implications | Q28266057 | ||
| Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study | Q28281530 | ||
| Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial | Q28290635 | ||
| Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents | Q28300892 | ||
| Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
| COMPARATIVE STUDIES ON THE BIFIDUS FLORA IN THE FECES OF INFANTS AND ADULTS. WITH A CONTRIBUTION TO CLASSIFICATION AND NOMENCLATURE OF BIFIDUS STRAINS | Q50734878 | ||
| Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. | Q51479359 | ||
| Suppressive effects of bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model. | Q51741805 | ||
| Early differences in fecal microbiota composition in children may predict overweight. | Q53219254 | ||
| Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease. | Q53444099 | ||
| Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. | Q53613669 | ||
| Bifidobacterium breve B-3 exerts metabolic syndrome-suppressing effects in the liver of diet-induced obese mice: a DNA microarray analysis. | Q54260099 | ||
| Intraoperative bacterial translocation detected by bacterium-specific ribosomal rna-targeted reverse-transcriptase polymerase chain reaction for the mesenteric lymph node strongly predicts postoperative infectious complications after major hepatecto | Q54400424 | ||
| Three-Month Feeding Integration With Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns. | Q55017832 | ||
| Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-α and short-chain fatty acids | Q56379208 | ||
| Association Between Childhood Migraine and History of Infantile Colic | Q56625834 | ||
| Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns | Q56979760 | ||
| Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea | Q57007134 | ||
| The microbiome-gut-brain axis: from bowel to behavior | Q57513693 | ||
| Establishment and development of intestinal microbiota in preterm neonates | Q57677293 | ||
| The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis | Q29616351 | ||
| Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. | Q30581062 | ||
| Metagenomic analyses of an uncultured viral community from human feces | Q33193633 | ||
| Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. | Q33231186 | ||
| Epidemiology of childhood constipation: a systematic review | Q33259975 | ||
| Viral diversity and dynamics in an infant gut. | Q33341580 | ||
| Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing | Q33385985 | ||
| Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial | Q33440895 | ||
| Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants | Q33596978 | ||
| Consecutive Intake of Fermented Milk Containing Bifidobacterium breve Strain Yakult and Galacto-oligosaccharides Benefits Skin Condition in Healthy Adult Women | Q33665964 | ||
| Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children | Q33671587 | ||
| Dynamics and Clinical Evolution of Bacterial Gut Microflora in Extremely Premature Patients | Q33723632 | ||
| Protective nutrients and bacterial colonization in the immature human gut. | Q33823136 | ||
| Archaea as emerging organisms in complex human microbiomes | Q33850774 | ||
| Fecal microbiota in premature infants prior to necrotizing enterocolitis | Q33932986 | ||
| The importance of the ratio of omega-6/omega-3 essential fatty acids | Q33962634 | ||
| Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064 | Q33997640 | ||
| Effects of four Bifidobacteria on obesity in high-fat diet induced rats | Q33998629 | ||
| The first 1000 cultured species of the human gastrointestinal microbiota. | Q34041082 | ||
| Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging | Q34051652 | ||
| Cytokine and growth factor involvement in schizophrenia--support for the developmental model | Q34111013 | ||
| Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge | Q34143650 | ||
| Colonic anti-inflammatory mechanisms of conjugated linoleic acid | Q34162918 | ||
| The relationship between gut microbiota and weight gain in humans | Q34242302 | ||
| Early-life gut microbiota under physiological and pathological conditions: the central role of combined meta-omics-based approaches. | Q34258388 | ||
| Diversity of bifidobacteria within the infant gut microbiota | Q34273797 | ||
| Gut-brain axis: how the microbiome influences anxiety and depression | Q34326411 | ||
| Psychobiotics: a novel class of psychotropic | Q34350349 | ||
| Monostrain, multistrain and multispecies probiotics--A comparison of functionality and efficacy | Q34353982 | ||
| Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization | Q34398619 | ||
| Safety assessment of probiotics for human use. | Q34503589 | ||
| Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification. | Q34505571 | ||
| Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. | Q34546569 | ||
| Early development of the gut microbiota and immune health | Q34569160 | ||
| A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome | Q39396709 | ||
| Small bowel bacterial overgrowth syndrome | Q39673180 | ||
| Gut microbiota is not modified by Randomized, Double-blind, Placebo-controlled Trial of VSL#3 in Diarrhea-predominant Irritable Bowel Syndrome | Q40306009 | ||
| Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies | Q40382307 | ||
| Intestinal Microbiota in Pediatric Surgical Cases Administered Bifidobacterium Breve: A Randomized Controlled Trial | Q40799001 | ||
| Occurrence of necrotizing enterocolitis may be dependent on patterns of bacterial adherence and intestinal colonization: studies in Caco-2 tissue culture and weanling rabbit models | Q41459007 | ||
| The Elevated Rate of Cesarean Section and Its Contribution to Non-Communicable Chronic Diseases in Latin America: The Growing Involvement of the Microbiota. | Q41471255 | ||
| Infantile colic, regurgitation, and constipation: an early traumatic insult in the development of functional gastrointestinal disorders in children? | Q41694349 | ||
| Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice | Q42263596 | ||
| Inhibitory effects of Bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones | Q42487252 | ||
| Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease | Q42677255 | ||
| Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice | Q42684907 | ||
| Long-term prognosis for childhood constipation: clinical outcomes in adulthood | Q43317716 | ||
| Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy. | Q43354333 | ||
| Necrotizing enterocolitis prevention: art or science? | Q43476621 | ||
| Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants | Q43618318 | ||
| Use of VSL[sharp]3 in the treatment of rotavirus diarrhea in children: preliminary results | Q43744503 | ||
| Variable effects of short chain fatty acids and lactic acid in inducing intestinal mucosal injury in newborn rats | Q44190252 | ||
| Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species | Q44256651 | ||
| Enhancement of Immune Response in Peyer's Patch Cells Cultured with Bifidobacterium breve | Q44265309 | ||
| Too much short chain fatty acids cause neonatal necrotizing enterocolitis | Q44764010 | ||
| Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains | Q44783869 | ||
| Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains | Q44851597 | ||
| Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. | Q45126890 | ||
| Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants | Q45206544 | ||
| Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. | Q45975763 | ||
| Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis | Q46143449 | ||
| Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine | Q46237114 | ||
| The Association of Bifidobacterium breve BR03 and B632 is Effective to Prevent Colics in Bottle-fed Infants: A Pilot, Controlled, Randomized, and Double-Blind Study | Q46478055 | ||
| Long-term ecological impacts of antibiotic administration on the human intestinal microbiota | Q46878665 | ||
| Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network | Q47180140 | ||
| Effects of oral administration of bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants | Q47304150 | ||
| Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial | Q47407913 | ||
| Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey | Q47713633 | ||
| Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells | Q47945739 | ||
| Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: a randomized double-blinded placebo study | Q48089690 | ||
| Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses | Q36747196 | ||
| Insulin sensitivity: modulation by nutrients and inflammation | Q36848937 | ||
| Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950. | Q37335567 | ||
| Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis | Q37421142 | ||
| A Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates Partial Non-Responsiveness to Whey Protein in Mice Orally Exposed to β-Lactoglobulin-Derived Peptides. | Q37580776 | ||
| Health benefits of probiotics: are mixtures more effective than single strains? | Q37828084 | ||
| Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management. | Q37910352 | ||
| Bifidobacterium breve UCC2003 surface exopolysaccharide production is a beneficial trait mediating commensal-host interaction through immune modulation and pathogen protection | Q38020020 | ||
| The human milk microbiota: origin and potential roles in health and disease. | Q38043176 | ||
| Association between caesarean section and childhood obesity: a systematic review and meta-analysis | Q38370796 | ||
| A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. | Q38391245 | ||
| Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. | Q38437716 | ||
| A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients | Q38730502 | ||
| Probiotics, gut microbiota, and their influence on host health and disease. | Q38921638 | ||
| VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study | Q39286213 | ||
| Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity | Q34622388 | ||
| Is Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study | Q34623410 | ||
| Contribution of diet to the composition of the human gut microbiota | Q34667841 | ||
| A mathematical model of quorum sensing regulated EPS production in biofilm communities | Q34957400 | ||
| Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial | Q35110845 | ||
| Inflammatory concepts of obesity | Q35151595 | ||
| Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota | Q35211993 | ||
| Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. | Q35233808 | ||
| Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria | Q35266351 | ||
| Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial | Q35285379 | ||
| Capability of the two microorganisms Bifidobacterium breve B632 and Bifidobacterium breve BR03 to colonize the intestinal microbiota of children | Q35309603 | ||
| The probiotic Bifidobacterium breve B632 inhibited the growth of Enterobacteriaceae within colicky infant microbiota cultures. | Q35325901 | ||
| Gut microbiota are related to Parkinson's disease and clinical phenotype | Q35492461 | ||
| Probiotics and gut health in infants: A preliminary case-control observational study about early treatment with Lactobacillus reuteri DSM 17938. | Q35565361 | ||
| A pilot study of Bifidobacterium breve in neonates undergoing surgery for congenital heart disease | Q35584456 | ||
| Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis | Q35594493 | ||
| Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC) | Q35595770 | ||
| Neurotrophic mechanisms in drug addiction | Q35682958 | ||
| Comparison of the gut microbiota profile in breast-fed and formula-fed Korean infants using pyrosequencing | Q35696794 | ||
| Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial | Q35718362 | ||
| High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome | Q35791181 | ||
| Role of probiotics VSL#3 in prevention of suspected sepsis in low birthweight infants in India: a randomised controlled trial | Q35844199 | ||
| Fungal microbiota dysbiosis in IBD. | Q35914203 | ||
| Benefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates - A Retrospective Cohort Study | Q35949040 | ||
| Evaluation of the effects of intrapartum antibiotic prophylaxis on newborn intestinal microbiota using a sequencing approach targeted to multi hypervariable 16S rDNA regions | Q35955365 | ||
| Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon | Q36000703 | ||
| Impact of Prematurity and Perinatal Antibiotics on the Developing Intestinal Microbiota: A Functional Inference Study | Q36005355 | ||
| Early Gut Microbiota Perturbations Following Intrapartum Antibiotic Prophylaxis to Prevent Group B Streptococcal Disease | Q36058824 | ||
| Effect of Bifidobacterium breve on the Intestinal Microbiota of Coeliac Children on a Gluten Free Diet: A Pilot Study. | Q36174419 | ||
| The Human Intestinal Microbiome in Health and Disease | Q36224014 | ||
| VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases | Q36563414 | ||
| Necrotising enterocolitis | Q36617416 | ||
| Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months | Q36698632 | ||
| Establishment and development of lactic acid bacteria and bifidobacteria microbiota in breast-milk and the infant gut | Q57677313 | ||
| Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial | Q57984339 | ||
| Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration | Q58786962 | ||
| VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 | ||
| Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003 | Q59697996 | ||
| Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues | Q59879866 | ||
| Bacteria of the human intestinal microbiota produce glycosidases specific for lacto-series glycosphingolipids | Q68659705 | ||
| Clinical effects of Bifidobacterium preparations on pediatric intractable diarrhea | Q69451565 | ||
| The effects of Bifidobacterium breve administration on campylobacter enteritis | Q70415668 | ||
| Sorbitol-fermenting bifidobacteria as specific indicators of human faecal pollution | Q71145276 | ||
| Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects | Q73140596 | ||
| Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia | Q73357715 | ||
| Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits | Q74237611 | ||
| Effects of soya milk and Bifidobacterium-fermented soya milk on plasma and liver lipids, and faecal steroids in hamsters fed on a cholesterol-free or cholesterol-enriched diet | Q74321133 | ||
| Neonatal late-onset bloodstream infection: attributable mortality, excess of length of stay and risk factors | Q74370022 | ||
| Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure | Q74564631 | ||
| Soymilk products affect ethanol absorption and metabolism in rats during acute and chronic ethanol intake | Q77584632 | ||
| Human milk provides peptides highly stimulating the growth of bifidobacteria | Q77664646 | ||
| The value of rectal biopsy in the diagnosis of ulcerative colitis | Q79007944 | ||
| Transforming growth factor-beta: an important cytokine in the mucosal immune response | Q79216660 | ||
| Conditions of bifidobacterial colonization in preterm infants: a prospective analysis | Q80220050 | ||
| Effects of bifidobacterium breve supplementation on intestinal flora of low birth weight infants | Q80877314 | ||
| Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis | Q81016792 | ||
| Necrotizing enterocolitis | Q83236511 | ||
| Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study | Q83986587 | ||
| Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis | Q84437254 | ||
| Early use of probiotics is important therapy in infants with severe congenital anomaly | Q84569028 | ||
| Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial | Q84976450 | ||
| Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938 | Q86100113 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bacteria | Q10876 |
| environment | Q2249676 | ||
| P304 | page(s) | 1723 | |
| P577 | publication date | 2018-11-10 | |
| P1433 | published in | Nutrients | Q7070485 |
| P1476 | title | Therapeutic Microbiology: The Role of as Food Supplement for the Prevention/Treatment of Paediatric Diseases | |
| P478 | volume | 10 |
| Q92151884 | Effects of Linoleic Acid on Gut-Derived Bifidobacterium breve DSM 20213: A Transcriptomic Approach |
| Q92210703 | Exploring the Science behind Bifidobacterium breve M-16V in Infant Health |
| Q64969076 | Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. |
| Q92881371 | Lactate-Fortified Puerariae Radix Fermented by Bifidobacterium breve Improved Diet-Induced Metabolic Dysregulation via Alteration of Gut Microbial Communities |
| Q90429144 | Preterm neonatal immunology at the intestinal interface |
| Q64258328 | Probiotics and Prebiotics in Pediatrics: What Is New? |
| Q90567912 | The Gut Microbiota in Celiac Disease and probiotics |
Search more.